Sources | Names Used |
---|---|
CTRPv2 | BRD9876:MK-1775 (4:1 mol/mol) |
PharmacoGx | BRD9876:MK-1775 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CALU | CTRPv2 | pan-cancer | AAC | -0.44 | 0.003 |
mRNA | SLFN5 | CTRPv2 | pan-cancer | AAC | -0.36 | 0.003 |
mRNA | EXO1 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.003 |
mRNA | BTBD9 | CTRPv2 | pan-cancer | AAC | -0.33 | 0.003 |
mRNA | IGFBP5 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.003 |
mRNA | IFNB1 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.003 |
mRNA | KCNV2 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.003 |
mRNA | TBC1D3L | CTRPv2 | pan-cancer | AAC | -0.32 | 0.003 |
mRNA | RP11-613M10.8 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.003 |
mRNA | HNRNPC | CTRPv2 | pan-cancer | AAC | 0.38 | 0.003 |